Lv1
50 积分 2023-02-17 加入
PGV001, a multi-peptide personalized neoantigen vaccine platform: Phase I study in patients with solid and hematological malignancies in the adjuvant setting
11天前
已完结
Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide–Based Vaccine in Patients With Refractory Advanced Non–Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study
11天前
已完结
Cryptic but critical: non-canonical antigens in cancer immunotherapy
1个月前
已完结
Radiation-induced amphiregulin drives tumour metastasis
3个月前
已完结
Phase III randomized trial comparing neoadjuvant paclitaxel+platinum to 5-fluorouracil+platinum in esophageal/GEJ squamous cell carcinoma
5个月前
已完结
Tislelizumab combined with nab‐paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two‐cohort, phase 2 trial
5个月前
已完结
Nanotechnology for next-generation cancer immunotherapy: State of the art and future perspectives
5个月前
已完结
Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial
5个月前
已完结
Lung cancer vaccination from concept to reality: A critical review of clinical trials and latest advances
6个月前
已完结
皖公网安备34019202002308
